A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

Abstract Background We describe a randomized, non-blinded Phase II interventional study to assess the safety and efficacy of stereotactic ablative radiotherapy (SABR) for hormone-sensitive oligometastatic prostate adenocarcinoma, and to describe the biology of the oligometastatic state using immunol...

Full description

Bibliographic Details
Main Authors: Noura Radwan, Ryan Phillips, Ashley Ross, Steven P. Rowe, Michael A. Gorin, Emmanuel S. Antonarakis, Curtiland Deville, Stephen Greco, Samuel Denmeade, Channing Paller, Daniel Y. Song, Maximilian Diehn, Hao Wang, Michael Carducci, Kenneth J. Pienta, Martin G. Pomper, Theodore L. DeWeese, Adam Dicker, Mario Eisenberger, Phuoc T. Tran
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Cancer
Subjects:
Prostate cancer
Stereotactic body radiation therapy
Stereotactic ablative radiotherapy
Oligometastasis
Online Access:http://link.springer.com/article/10.1186/s12885-017-3455-6

Internet

http://link.springer.com/article/10.1186/s12885-017-3455-6

Similar Items